Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Interstitial Cystitis: early-phase trial registry
12 of 28 indexed Interstitial Cystitis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #577 of 28,707 conditions by registered trial count.
28 US clinical trials · 12 currently recruiting · #577 of 28,707 conditions by registered trial count
Interstitial Cystitis: 28 US clinical trials tracked, 12 recruiting.
Interstitial Cystitis is the subject of 28 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is Corewell Health East, running 4 of these trials.
Enrollment posture brief
Registry condition interstitial-cystitis
OPEN 12 | RECR 43% | LATE 3 | EARLY 8 | RANK #577 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Acute Myelogenous Leukemia (AML) (43% recruiting · 7 trials)
Interstitial Cystitis lists 12 open slots (43% of 28 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Interstitial Cystitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Interstitial Cystitis is recruiting above its size-band peers.
12 of 28 indexed trials (42.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Interstitial Cystitis trials is spread across many organizations.
Corewell Health East accounts for 4 of 28 trials (14.3%). 21 distinct sponsors appear on at least one study for this condition label.
-
Typical Interstitial Cystitis enrolment sits around 90 participants.
Median target enrolment is 90 among the 27 trials that report a genuine target (sentinel values excluded). 15 of those (55.6%) plan for fewer than 100 participants.
-
Interstitial Cystitis research is mostly interventional.
22 interventional and 6 observational studies make up this index (78.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
28 total, page 1 of 1
Identifying Genetic Causes of IC/BPS
Boston Children's Hospital
NCT00389142
Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Boston Children's Hospital
NCT00499317
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
State University of New York at Buffalo
NCT05127616
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
Vanderbilt University Medical Center
NCT06299683
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
Vaneltix Pharma
NCT05737121
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
University of Louisville
NCT04845217
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
David Sheyn
NCT06096597
Investigation of PEMF Therapy for Female Patients With IC/BPS
Wake Forest University Health Sciences
NCT05149573
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
University of Southern California
NCT04734847
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
Vaneltix Pharma
NCT06394830
Acupuncture First for IC/BPS
University Hospitals Cleveland Medical Center
NCT06366269
Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis
Wake Forest University Health Sciences
NCT04734106
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
Medtronic - MITG
NCT05696444
A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain
Jocelyn Fitzgerald
NCT05658874
Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome
Stanford University
NCT05485207
The Women's Urology Center/WISH Database Project
Corewell Health East
NCT00379002
Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study
Pathnostics
NCT03931538
Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis
Corewell Health East
NCT01138800
Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00124306
Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation
University of New Mexi
NCT04820855
Clinical Trial Comparing Two Bladder Instillations for IC/BPS
Olivia Cardenas-Trowers, M.D.
NCT03463915
Study of U101 for Bladder Pain and/or Urgency
Urigen
NCT00256542
Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain
Summa Health System
NCT00554320
Urinary Biomarkers Characteristic to Interstitial Cystitis
Corewell Health East
NCT00971568
The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients
TriHealth
NCT03722992
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Kenneth Peters, MD
NCT01731470
Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With IC
Corewell Health East
NCT00420550
Genetics of Interstitial Cystitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00237081
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 5 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Interstitial Cystitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Interstitial Cystitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Interstitial Cystitis page
28 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 12 Interstitial Cystitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Corewell Health East sponsors the most Interstitial Cystitis trials on record, review their full trial history before evaluating a specific study. See Corewell Health East's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Interstitial Cystitis condition card totals 28 registered trials; most-linked intervention VNX001; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.